Fact checked byKristen Dowd

Read more

April 01, 2024
1 min read
Save

Tranexamic acid may improve visualization, OR time for arthroscopic rotator cuff repair

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Tranexamic acid improved visualization, operative time and pain scores for patients undergoing arthroscopic rotator cuff repair.
  • Further research is needed to evaluate the optimal dosing of tranexamic acid.
Perspective from Grant E. Garrigues, MD

Published results from a systematic review and meta-analysis showed tranexamic acid improved visualization, operative time and postoperative pain scores for patients undergoing arthroscopic rotator cuff repair.

Eoghan T. Hurley, MB, MCh, PhD, and colleagues from Duke University performed a level 1 systematic review and meta-analysis of six randomized controlled trials which compared the use of tranexamic acid in 231 patients who underwent arthroscopic rotator cuff repair vs. a control group of 219 patients who underwent the same procedure without tranexamic acid.

Shoulder injection
Tranexamic acid improved visualization, operative time and pain scores for patients undergoing arthroscopic rotator cuff repair. Image: Adobe stock

Outcome measures included intraoperative arthroscopic visual scores, postoperative VAS pain scores, operative time, pump pressures and shoulder swelling, according to the study.

Among the five studies which reported on visualization, three studies found patients who received tranexamic acid had “significantly superior” mean arthroscopic visual scores compared with the control group. Mean postoperative VAS score was 3.3 for patients who received tranexamic acid and 4.1 for control patients. Researchers noted this was a statistically significant difference.

Researchers also found a statistically significant difference in mean weighted operative time for patients who received tranexamic acid (79.3 minutes) vs. control patients (88.8 minutes). They found no differences between the groups for intraoperative pump pressures or shoulder swelling.

“Further research should be done to evaluate the optimal dosing of tranexamic acid in these patients as well as the optimal administration rout — intra-articular or intravenous,” the researchers wrote in the study.